PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines

Plan marks 10 successful years; raises bar, heightens focus on achieving 80 percent effective vaccine

		IMAGE: This is a malaria parasite lifecycle. Click here for more information.

NAIROBI, Kenya, November 2, 2009 – Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.